-
BioPharma Dive – AI / Data3 months agoA biotech VC sees early signs of a turnaround for startups
After a lengthy downturn, renewed optimism is building among young drugmakers and their backers as a new funding wave takes shape, said Santé Ventures’ Omar Khalil.
-
AI & Machine Learning in Biotechnology3 months agoDid we undercount Covid deaths by 155,000?
It’s Breakthrough Summit East day! If you weren’t able to snag a ticket to join us in New York City to hear from the leaders advancing...
-
AI & Machine Learning in Biotechnology3 months agoSTAT+: Pharmalittle: We’re reading about a Lilly weight loss trial, TrumpRx shortcomings, and more
Top of the morning to you, and a fine one it is. Despite dreary, gray skies and chilly temperatures, the Pharmalot campus is humming with activity,...
-
Biotech Industry Intelligence3 months ago
Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness
Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness
-
Biotech Industry Intelligence3 months ago
GSK liver drug wins FDA approval
GSK liver drug wins FDA approval
-
Fierce Biotech3 months ago
Pfizer adds to Seagen scrap heap with another early cancer candidate cull
About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, the company has trimmed another branch....
-
Uncategorized3 months agoFDA grants Fast Track Designation to rare disease treatment
The US Food and Drug Administration (FDA) has granted Fast Track Designation to a treatment for the rare paediatric disease late-infantile neuronal ceroid lipofuscinosis (LINCL/CLN2 disease). ...
-
Biotech Industry Intelligence3 months ago
Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail
Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail
-
Uncategorized3 months agoGenomics initiative could boost AI-designed therapeutics
A new initiative is set to generate and model biological data at the trillion-gene scale, paving the way to scale AI-designed therapeutics. The Trillion Gene Atlas,...
-
BioPharma Dive – AI / Data3 months agoAstraZeneca to boost cell therapy capabilities with new China investment
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
An obesity drug deep-dive, and peptides move mainstream
